Clinical Trial Update: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-911 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study update showing completion of safety, tolerability, and pharmacokinetics assessment for SUVN-911 in healthy subjects, with the target indication li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• SUVN-911

Snippet

Sponsor: Suven Life Sciences Limited | Conditions: Depressive Disorder, Major | Phase 1 | Status: COMPLETED